FOXP3 and type 1 diabetes mellitus: Demethylation progressed gradually, year by year, during 3 years of 11 Foxp3-positive T cell genes, presumably gaining suppressive capabilities against diabetogenic T cells in insulin-dependent diabetes patients [42].